Is Sun Pharma a good buy for long term?

2019-08-17 by No Comments

Is Sun Pharma a good buy for long term?

Sun Pharma Kotak Securities has a ‘buy’ rating on the stock with a target price of Rs 525. The brokerage said that post-correction, Sun Pharma has formed strong reversal formation near an important retracement level. Emkay Global also has a ‘buy’ rating on Sun Pharma with a target price of Rs 560.

Why is Sun Pharma going up?

Sun Pharma’s 10 per cent rise came after the company’s firm but lower-than-expected numbers for the quarter ended June. The other factor that drove investors to rush to bid for Sun Pharma’s stock is the fact that the company did not make any mention of pricing pressure in the US.

What is wrong with Sun Pharma?

That warning cited several problems at Sun’s Karkhadi, Gujarat facility including deficient cGMP manufacturing practices for both APIs and finished drug products sold in the US. “These violations and deviations cause your drug products and APIs to be adulterated,” said the FDA.

Which is the best pharma stock to buy?

10 Best Pharma Company Stocks To Invest Now In India-2021

  • Sun Pharmaceuticals.
  • Divis Laboratories. Stock Price: Rs 4, 033.
  • Dr. Reddy’s Lab.
  • Cipla Ltd. Stock Price: Rs 904.
  • Cadila Healthcare. Stock Price: Rs 617.
  • Lupin. Stock Price: Rs 1,176.45.
  • Torrent Pharmaceuticals. Stock Price: Rs 2,727.
  • Abbott India. Stock Price: Rs 16,100.

Which Pharma share is best to buy now?

Top 10 pharma stocks to buy in India [2021]

  • Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd is a multinational Indian company situated in Mumbai.
  • Divi’s Laboratories.
  • Cipla Ltd.
  • Biocon Ltd.
  • Torrent Pharmaceuticals Ltd.
  • AurobindoPharma Ltd.
  • Lupin Ltd.
  • Cadila Healthcare Ltd.

Is Sun Pharma reputable?

Very good company to work.

Is Sun Pharma a debt free company?

Debt Level: SUNPHARMA’s debt to equity ratio (6.8%) is considered satisfactory. Reducing Debt: SUNPHARMA’s debt to equity ratio has reduced from 23.2% to 6.8% over the past 5 years….Debt to Equity History and Analysis.

Jun 29 2021
debt ₹33.430b
equity ₹494.798b 6.8%

Where is Sun Pharmaceuticals located?

Our U.S. headquarters are in Princeton, New Jersey, and we have distribution and customer service teams at multiple locations across the country. Sun Pharma is present in the U.S. through its legal entities and its subsidiary, Taro Pharmaceuticals.

Which is the stock code of Sun Pharma?

Sun Pharma is in the Pharmaceuticals sector. It is listed on the BSE with a BSE Code of 524715 and the NSE with an NSE Code of SUNPHARMA.

What kind of company is Sun Pharmaceutical Industries?

Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It operates through the following geographical segments: India, United States of America, Emerging Markets, and Rest of the World.

What is the dividend yield of Sun Pharmaceutical Industries?

For the year ending March 2019 Sun Pharmaceutical Industries has declared an equity dividend of 275.00% amounting to Rs 2.75 per share. At the current share price of Rs 452.10 this results in a dividend yield of 0.61%.

How to contact Sun Pharma in the United States?

For information related to a Sun Product marketed in the United States, please call 1-833-SUN-INFO (833-786-4636) Our Medical Information Specialists are available 8:00AM-8:00PM ET; Monday to Friday except holidays. Sun Pharmaceutical Industries Inc., 2 Independence Way,